Bausch Health Companies (TSE:BHC) Trading Down 1.5%

Bausch Health Companies Inc. (TSE:BHC) shares traded down 1.5% during trading on Wednesday . The company traded as low as C$10.25 and last traded at C$10.27. 34,054 shares were traded during mid-day trading, a decline of 90% from the average session volume of 352,127 shares. The stock had previously closed at C$10.43.

Wall Street Analysts Forecast Growth

Separately, Raymond James raised Bausch Health Companies to a “hold” rating in a research report on Wednesday, July 10th.

Bausch Health Companies Stock Down 24.6 %

The business has a 50-day moving average price of C$9.27 and a 200-day moving average price of C$10.95. The company has a market capitalization of C$2.88 billion, a price-to-earnings ratio of -5.64, a price-to-earnings-growth ratio of 0.21 and a beta of 0.90. The company has a quick ratio of 0.58, a current ratio of 1.23 and a debt-to-equity ratio of 7,583.76.

Bausch Health Companies (TSE:BHC) last issued its quarterly earnings results on Thursday, May 2nd. The company reported C$0.80 earnings per share for the quarter, missing analysts’ consensus estimates of C$1.02 by C($0.22). Bausch Health Companies had a negative net margin of 5.07% and a negative return on equity of 686.52%. The business had revenue of C$2.90 billion for the quarter, compared to analysts’ expectations of C$2.98 billion. As a group, equities analysts anticipate that Bausch Health Companies Inc. will post 4.85 earnings per share for the current fiscal year.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.